Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).
European Projects
To find more information, please, get in touch with the International Management team at oficina.idi(ELIMINAR)@irycis.org
RETENTION
H2020
 
                                            heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)
RESILIENCE
H2020
 
                                            Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines (945118).
VISION
H2020
 
                                            Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers (857381)
MICROCARE
FP7
 
                                            A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.
3TR
IMI / IHI
 
                                            Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory and Allergic Conditions
Conect4Children
IMI / IHI
 
                                            The conect4children (collaborative network for European clinical trials for children (c4c)
EURECA
FP7
 
                                            European prospective cohort study on Enterobacteriaceae showing resistance to carbapenems
ANTICIPATE
FP7
 
                                            Assessment of the incidence of Clostridium difficile infections in hospitalized patients on antibiotic treatment
ARTHR-IS
FP7
 
                                            Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection due to Staphylococcus aureus after primary knee or hip joint replacement
REVISIT
FP7
 
                                            Phase III randomized, open-label, comparative clinical trial to determine the efficacy and safety of aztreonam-avibactam (ATM-AVI)
MPI-AGE
FP7
Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons.
 
                                        